Remission rate of transcranial magnetic stimulation compared with electroconvulsive therapy: a case-control study

References

• de Sousa RT, Zanetti MV, Brunoni AR. Challenging treatment-resistant major depressive disorder: a roadmap for improved therapeutics. Curr Neuropharmacol. 2015;13:616–635.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917.
   PubMed Web of Science ®Google Scholar
• Park SC, Kim JM, Jun TY, et al. How many different symptom combinations fulfil the diagnostic criteria for major depressive disorder? Results from the CRESCEND study. Nord J Psychiatry. 2017;71:217–222.
   PubMed Web of Science ®Google Scholar
• Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53:649–659.
   PubMed Web of Science ®Google Scholar
• Aleman A, Slotema CW, Sommer IE. rTMS deserves a fair chance as a novel treatment for depression. Acta Psychiatr Scand. 2014;130:324–325.
   PubMed Web of Science ®Google Scholar
• George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry. 2011;168:356–364.
   PubMed Web of Science ®Google Scholar
• Chervyakov AV, Chernyavsky AY, Sinitsyn DO, et al. Possible mechanisms underlying the therapeutic effects of transcranial magnetic stimulation. Front Hum Neurosci. 2015;9:303.
   PubMed Web of Science ®Google Scholar
• Bakker N, Shahab S, Giacobbe P, et al. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation. Brain Stimul. 2015;8:208–215.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Van den Eynde F, Daskalakis ZJ. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J Clin Psychiatry. 2013;74:e122–e129.
   PubMed Web of Science ®Google Scholar
• Teng S, Guo Z, Peng H, et al. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: session-dependent efficacy: a meta-analysis. Eur Psychiatry. 2017;41:75–84.
   PubMed Web of Science ®Google Scholar
• Concerto C, Lanza G, Cantone M, et al. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study. Int J Psychiatry Clin Pract. 2015;19:252–258.
   PubMed Web of Science ®Google Scholar
• Kedzior KK, Reitz SK, Azorina V, et al. The antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) in the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials. Depress Anxiety. 2015;32:193–203.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev. 2002;(2):CD003493.
   PubMedGoogle Scholar
• Health Quality Ontario. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials. Ont Health Technol Assess Ser. 2016;16(5):1–66.
   Google Scholar
• Richieri R, Jouvenoz D, Verger A, et al. Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study. Eur J Nucl Med Mol Imaging. 2017;44:1051–1055.
   PubMed Web of Science ®Google Scholar
• Theleritis C, Sakkas P, Paparrigopoulos T, et al. Two versus one high-frequency repetitive transcranial magnetic stimulation session per day for treatment-resistant depression: a randomized sham-controlled trial. Response to Andrade and colleagues. J ECT. 2017;33:143.
   Google Scholar
• Johnson KA, Baig M, Ramsey D, et al. Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul. 2013;6:108–117.
   PubMed Web of Science ®Google Scholar
• Okkels N, Mogensen RB, Crean LC, et al. Treatment profiles in a Danish psychiatric university hospital department. Nord J Psychiatry. 2017;71:289–295.
   PubMed Web of Science ®Google Scholar
• Brakemeier EL, Luborzewski A, Danker-Hopfe H, et al. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res. 2007;41:395–403.
   PubMed Web of Science ®Google Scholar
• Wu GR, Baeken C. Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency? Brain Imaging Behav. 2017;11:8–16.
   PubMed Web of Science ®Google Scholar
• Rostami R, Kazemi R, Nitsche MA, et al. Clinical and demographic predictors of response to rTMS treatment in unipolar and bipolar depressive disorders. Clin Neurophysiol. 2017;128:1961–1970.
   PubMed Web of Science ®Google Scholar
• Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med. 2007;357:1939–1945.
   PubMed Web of Science ®Google Scholar
• Ren J, Li H, Palaniyappan L, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis. Prog Neuropsychophar-macol Biol Psychiatry. 2014;51:181–189.
   PubMed Web of Science ®Google Scholar
• Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry. 2000;15:s415–s424.
   Google Scholar
• Schulze-Rauschenbach SC, Harms U, Schlaepfer TE, et al. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry. 2005;186:410–416.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. Nationella riktlinjer för vård vid depression och ångestsyndrom-Stöd för styrning och ledning [Welfare. National guidelines for depression and anxiety disorder support-support for management and m anagement]. Stockholm: Socialstyrelsen; 2017. Swedish.
   Google Scholar
• Nordanskog P, Hulten M, Landen M, et al. Electroconvulsive therapy in Sweden 2013: data from the National Quality Register for ECT. J ECT. 2015;31:263–267.
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute of Health, Psychopharmacology research branch; 1976.
   Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
   PubMed Web of Science ®Google Scholar
• Svanborg P, Asberg M. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord. 2001;64:203–216.
   PubMed Web of Science ®Google Scholar
• Westin GG, Bassi BD, Lisanby SH, et al. Determination of motor threshold using visual observation overestimates transcranial magnetic stimulation dosage: safety implications. Clin Neurophysiol. 2014;125:142–147.
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Chaimani A, Moffa AH, et al. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis. JAMA Psychiatry. 2017;74:143–152.
   PubMed Web of Science ®Google Scholar
• Nordenskjold A, Martensson B, Pettersson A, et al. Effects of Hesel-coil deep transcranial magnetic stimulation for depression - a systematic review. Nord J Psychiatry. 2016;70:492–497.
   PubMed Web of Science ®Google Scholar
• Avery DH, Holtzheimer PE, Fawaz W, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006;59:187–194.
   PubMed Web of Science ®Google Scholar
• Loo C, Mitchell P, Sachdev P, et al. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry. 1999;156:946–948.
   PubMed Web of Science ®Google Scholar
• Herwig U, Fallgatter AJ, Hoppner J, et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry. 2007;191:441–448.
   PubMed Web of Science ®Google Scholar
• Huang ML, Luo BY, Hu JB, et al. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial. Aust N Z J Psychiatry. 2012;46:257–264.
   PubMed Web of Science ®Google Scholar
• Nordenskjöld A, von Knorring L, Engström I. Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders–a population based study. BMC Psychiatry. 2012;12:17–115.
   PubMed Web of Science ®Google Scholar
• Brus O, Cao Y, Gustafsson E, et al. Self-assessed remission rates after electroconvulsive therapy of depressive disorders. Eur Psychiatry. 2017;45:154–160.
   PubMed Web of Science ®Google Scholar
• Fantino B, Moore N. The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder. BMC Psychiatry. 2009;9:26.
   PubMed Web of Science ®Google Scholar
• Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depress Res Treat. 2014;2014:1.
   Google Scholar